JOSEPH M. MAHADY

Corporate Board Profile

Tech Score: 0/100

ALBEMARLE CORP

Filing Date	Source Excerpt
2013-03-28	Joseph M. Mahady; age 59; Director since February 2012; retired, having previously served as President of Wyeth Pharmaceuticals, Inc. Serves on Audit Committee and Executive Compensation Committee. Compensation table shows total compensation of $163,107.
2014-03-28	Joseph M. Mahady; age 60; Director since February 2012; retired, having previously served as President of Wyeth Pharmaceuticals, Inc., a global manufacturer of pharmaceutical products from January 2008 until Wyeth was acquired by Pfizer Inc. in October 2009. Prior to assuming these responsibilities, he served as Senior Vice President and President – North America and Global Businesses, Wyeth Pharmaceuticals from June 2003 to June 2005, Senior Vice President and President, The Americas and Global Businesses, Wyeth Pharmaceuticals from June 2005 to February 2007 and Senior Vice President and President – Global Business, Wyeth Pharmaceuticals from February 2007 to December 2007. Other directorships: Cortendo AB (specialty pharmaceutical company), Discovery Laboratories, Inc. (specialty biotechnology company) and KV Pharmaceutical Company (specialty pharmaceutical company). Mr. Mahady's experience in leading global commercial operations and creating sustainable opportunities in emerging markets is an excellent resource for our Board. He has significant experience integrating companies following a merger or acquisition and a strong foundation in financial management.

Filing Date

Source Excerpt

2013-03-28

Joseph M. Mahady; age 59; Director since February 2012; retired, having previously served as President of Wyeth Pharmaceuticals, Inc. Serves on Audit Committee and Executive Compensation Committee. Compensation table shows total compensation of $163,107.

2014-03-28

Joseph M. Mahady; age 60; Director since February 2012; retired, having previously served as President of Wyeth Pharmaceuticals, Inc., a global manufacturer of pharmaceutical products from January 2008 until Wyeth was acquired by Pfizer Inc. in October 2009. Prior to assuming these responsibilities, he served as Senior Vice President and President – North America and Global Businesses, Wyeth Pharmaceuticals from June 2003 to June 2005, Senior Vice President and President, The Americas and Global Businesses, Wyeth Pharmaceuticals from June 2005 to February 2007 and Senior Vice President and President – Global Business, Wyeth Pharmaceuticals from February 2007 to December 2007. Other directorships: Cortendo AB (specialty pharmaceutical company), Discovery Laboratories, Inc. (specialty biotechnology company) and KV Pharmaceutical Company (specialty pharmaceutical company). Mr. Mahady's experience in leading global commercial operations and creating sustainable opportunities in emerging markets is an excellent resource for our Board. He has significant experience integrating companies following a merger or acquisition and a strong foundation in financial management.

WINDTREE THERAPEUTICS INC /DE/

Filing Date	Source Excerpt
2013-04-30	Joseph M. Mahady has served as a member of our Board since January 2013. The Audit Committee of the Board is a Standing Committee and currently consists of Bruce A. Peacock (Chairman), Joseph M. Mahady, and Marvin E. Rosenthale, Ph.D. The Compensation Committee of the Board is a Standing Committee and currently consists of John R. Leone (Chairman), Joseph M. Mahady and Bruce A. Peacock.
2014-04-28	Joseph M. Mahady has served as a member of our Board since January 2013. He is a member of the Board’s Audit and Compensation Committees. Effective June 11, 2013, the Compensation Committee recommended and the Board approved changes to the compensation of non-employee directors as follows: The following chart summarizes the cash and non-cash compensation paid to our non-employee directors during the year ended December 31, 2013. Joseph M. Mahady: $140,687 total.
2015-04-29	Joseph M. Mahady, age 62, has served as a member of our Board since January 2013. He is a member of the Board’s Audit and Compensation Committees. ... The following chart summarizes the cash and non-cash compensation paid to our non-employee directors during the year ended December 31, 2014. ... Joseph M. Mahady ... Total $75,522.
2016-05-24	Joseph M. Mahady, age 63, has served as a member of our Board since January 2013. He also serves as Chairman of the Board’s Compensation Committee and a member of the Audit Committee. ... Joseph M. Mahady $49,500 (Fees Earned or Paid in Cash), $8,000 (Stock Awards), $4,530 (Option Awards), Total $62,030.
2017-05-18	Joseph M. Mahady, age 64, has served as a member of our Board since January 2013. He also serves as Chairman of the Board’s Compensation Committee and a member of the Audit Committee. ... Joseph M. Mahady Fees Earned or Paid in Cash $52,000, Stock Awards $8,000, Option Awards $18,960, Total $78,960.

Data sourced from SEC filings. Last updated: 2026-02-03